Setshaba Research Centre | Pharmacy Department

Research site
2088 Block H, Pretoria, Gauteng, South Africa
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and hu...

Active, not recruiting
Human Metapneumovirus
Respiratory Syncytial Virus
Biological: Placebo
Biological: mRNA-1345

To evaluate the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine plus a homologous boostwith Ad26.COV2.S COVID-19 vaccine among Sisonke...

SARS CoV 2 Infection
Biological: Booster vaccine

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
Other: Placebo
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

Trial conditions

Tuberculosis (3 trials)
COVID-19 (2 trials)
HIV Infections (1 trial)
Hypersensitivity (1 trial)
Pulmonary Tuberculosis (1 trial)
Severe Acute Respiratory... (1 trial)
Streptococcal Infections (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems